'Nanodecoy' therapy binds and neutralizes SARS-CoV-2 virus

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds ...

page 1 from 40